Stock GLMD GALMED PHARMACEUTICALS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Galmed Pharmaceuticals Ltd.

Equities

GLMD

IL0011313900

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.3916 USD -0.23% Intraday chart for Galmed Pharmaceuticals Ltd. +5.04% -13.93%
Apr. 04 Galmed Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 15 Galmed Pharmaceuticals Ltd. Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of Nash and Liver Fibrosis CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Neutral

Neutral

Bearish

Resistance 0.4195 0.4565 1.190
Spread/Res.-6.65%-14.22%-67.09%
Spread/Supp.+33.06%+33.06%+28.35%
Support 0.2943 0.2943 0.3051

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. GLMD Stock
  4. Charts Galmed Pharmaceuticals Ltd.